NOTCH3 and pulmonary arterial hypertension: Since Notch3 signalling is a key regulator of vascular function and because it has a VSMC-specific expression pattern, it is not surprising that it has been considered as a candidate target in conditions involving pathological remodelling of blood vessels, including PAH.